Runcong Nie is associate chief physician of Department of Gastric Surgery,Sun Yat-sen University Cancer Center (SYSUCC). He received M.D. fromSun Yat-sen University at 2020 and finishedpostdoctoral trainingat SYSUCC during 2020-2022. His interest is the tumor microenvironment, tumor-immune interactions and drug resistance for GC. He had got the 2020 CSCO 35 under 35 Most Promising Oncologist Award and had published many important papers in high-impacted journals such as Nature Medicine, GUT, Mol Cancer, JAMA Netw Open, Adv Sci, JNCI and Eur J Cancer. 

Minimally invasive surgery for gastric cancer; Perioperative treatment and translational research for gastric cancer; Tumor microenvironment; Tumor-immune interactions

2009-2014: Undergraduate program at Zhongshan School of Sun Yat-sen University;

2014-2020:Master and Ph.D.programat Sun Yat-sen University Cancer Center,Sun Yat-sen 

1. Shu-Qiang Yuan#; Run-Cong Nie#; Ying Jin#; Cheng-Cai Liang#; Yuan-Fang Li#; Rui Jian; Xiao-Wei Sun; Ying-Bo Chen; Wen-Long Guan; Zi-Xian Wang; Hai-Bo Qiu; Wei Wang; Shi Chen; Dong-Sheng Zhang; Yi-Hong Ling; Shao-Yan Xi; Mu-Yan Cai; Chun-Yu Huang; Qiu-Xia Yang; Zhi-Min Liu; Yuan-Xiang Guan; Yong-Ming Chen; Ji-Bin Li; Xiong-Wen Tang; Jun-Sheng Peng; Zhi-Wei Zhou*; Rui-Hua Xu*; Feng Wang*; Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial, Nature Medicine, 2024, 30(2): 552-559

2. Cai XX#, Chen GM#, Zheng ZQ#, Yin YX#, Wang S#, Qiao L#, Chen XJ, Zhao BW, Duan JL, Liang CC, Zhang RP, Wei CZ, Zhang FY, Huang BW, Liu ZX, Zhou ZW, Xie D, Cai MY*, Yuan SQ*, Li YF*, Nie RC*. Transcriptional landscape and predictive potential of long noncoding RNAs in peritoneal recurrence of gastric cancer. Mol Cancer. 2024 Dec 30;23(1):284.

3. Li Y#, Zheng Y#, Huang J#, Nie RC#, Wu QN#, Zuo Z#, Yuan S, Yu K, Liang CC, Pan YQ, Zhao BW, Xu Y, Zhang Q, Zheng Y, Chen J, Zeng ZL, Wei W, Liu ZX*, Xu RH*, Luo HY*. CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases. Gut. 2024 Nov 12:gutjnl-2024-333617.

4. Zhou-Kai Zhao#; Ruo-Peng Zhang#; Guo-Ming Chen#; Man Nie#; Fei-Yang Zhang; Xiao-Jiang Chen; Jun Lin; Ze-Wei Chen; Fei-Zhi Lin; Cheng-Zhi Wei; Zi-Qi Zheng; Sheng-Hang Ruan; Bo-Wen Huang; Ying-Bo Chen*; Run-Cong Nie*; Anti-Helicobacter pylori Treatment in Patients With Gastric Cancer After Radical Gastrectomy, JAMA Network Open, 2024, 7(3): e243812

5. Run-Cong Nie#; Fo-Ping Chen#; Mariano Provencio#; Yun Wang#; Tom van den Ende; Hanneke W.M. van Laarhoven; Shu-Qiang Yuan; Miklos Pless; Stefanie Hayoz; Zhi-Wei Zhou; Yuan-Fang Li*; Sacha I. Rothschild*; Mu-Yan Cai*; Predictive value of radiological response, pathological response and elapse-free survival for overall survival in neoadjuvant immunotherapy trials: pooled analysis of 29 clinical trials, European Journal of Cancer, 2023, 186: 211-221

6. Jie Zhou#; Run-Cong Nie#; Zhang-Ping He#; Xiao-Xia Cai#; Jie-Wei Chen; Wen-Ping Lin; Yi-Xin Yin; Zhi-Cheng Xiang; Tian-Chen Zhu; Juan-Juan Xie; You-Cheng Zhang; Xin Wang; Peng Lin; Dan Xie*; Alan D D'Andrea*; Mu-Yan Cai*; STAG2 Regulates Homologous Recombination Repair and Sensitivity to ATM Inhibition, Advanced Science, 2023, 10(36): e2302494

7. Yuan-Fang Li#; Shu-Qiang Yuan#; Ying-Bo Chen#; Man Nie#; Ji-Bin Li; Guo-Ming Chen; Xiao-Jiang Chen; Ruo-Peng Zhang; Zi-Qi Zheng; Cheng-Zhi Wei; Zhi-Wei Zhou; Run-Cong Nie*; Yun Wang*; Evaluating Relapse-Free Survival as an Endpoint for Overall Survival in Adjuvant Immunotherapy Trials, JNCI: Journal of the National Cancer Institute, 2023, 115(9): 1085-1091

8. Nie RC#, Chen FP#, Yuan SQ#, Luo YS#, Chen S, Chen YM, Chen XJ, Chen YB, Li YF*, Zhou ZW*. Evaluation of objective response, disease control and progression-free survival as surrogate end-points for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials. European Journal of Cancer. 2019 Jan;106:1-11